These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 10097686)
1. Antimicrobial resistance patterns of Bacteroides fragilis group organisms in Korea. Lee K; Shin HB; Chong Y Yonsei Med J; 1998 Dec; 39(6):578-86. PubMed ID: 10097686 [TBL] [Abstract][Full Text] [Related]
2. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea. Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890 [TBL] [Abstract][Full Text] [Related]
3. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Betriu C; Cabronero C; Gomez M; Picazo JJ Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757 [TBL] [Abstract][Full Text] [Related]
4. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea. Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital. Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina. Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852 [TBL] [Abstract][Full Text] [Related]
9. Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012. Lee Y; Park YJ; Kim MN; Uh Y; Kim MS; Lee K Ann Lab Med; 2015 Sep; 35(5):479-86. PubMed ID: 26206683 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Cuchural GJ; Tally FP; Jacobus NV; Gorbach SL; Aldridge K; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP Antimicrob Agents Chemother; 1984 Aug; 26(2):145-8. PubMed ID: 6486758 [TBL] [Abstract][Full Text] [Related]
11. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Snydman DR; Jacobus NV; McDermott LA; Supran S; Cuchural GJ; Finegold S; Harrell L; Hecht DW; Iannini P; Jenkins S; Pierson C; Rihs J; Gorbach SL Antimicrob Agents Chemother; 1999 Oct; 43(10):2417-22. PubMed ID: 10508018 [TBL] [Abstract][Full Text] [Related]
12. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility]. Rodríguez E; Gamboa MM; Rodríguez C; Vargas P Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405 [TBL] [Abstract][Full Text] [Related]
13. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns. Aldridge KE; Ashcraft D; O'Brien M; Sanders CV Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF. Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of the Bacteroides fragilis group in the United States in 1981. Tally FP; Cuchural GJ; Jacobus NV; Gorbach SL; Aldridge KE; Cleary TJ; Finegold SM; Hill GB; Iannini PB; McCloskey RV; O'Keefe JP; Pierson CL Antimicrob Agents Chemother; 1983 Apr; 23(4):536-40. PubMed ID: 6859833 [TBL] [Abstract][Full Text] [Related]
16. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189 [TBL] [Abstract][Full Text] [Related]
17. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)]. Borobio MV; Domínguez MC; Pallares JA; Perea EJ Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620 [TBL] [Abstract][Full Text] [Related]
18. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. Cornick NA; Cuchural GJ; Snydman DR; Jacobus NV; Iannini P; Hill G; Cleary T; O'Keefe JP; Pierson C; Finegold SM J Antimicrob Chemother; 1990 Jun; 25(6):1011-9. PubMed ID: 2370237 [TBL] [Abstract][Full Text] [Related]
19. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Snydman DR; McDermott L; Cuchural GJ; Hecht DW; Iannini PB; Harrell LJ; Jenkins SG; O'Keefe JP; Pierson CL; Rihs JD; Yu VL; Finegold SM; Gorbach SL Clin Infect Dis; 1996 Dec; 23 Suppl 1():S54-65. PubMed ID: 8953108 [TBL] [Abstract][Full Text] [Related]